Answer
Ciprofloxacin may increase vorasidenib plasma concentrations through CYP1A2 inhibition, so concomitant use should be avoided and alternative therapies considered.
Sources for this answer
- Voranigo 10 mg film-coated tabletServier Laboratories Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked